Domenic Ciarico
Chief Executive Officer presso Par Sterile Products LLC
Profilo
Domenic Ciarico is currently the General Manager & Senior Vice President at Par Sterile Products LLC since 2018.
Previously, he worked as the Chief Commercial Officer, EVP-Sterile & Generic at Endo International Plc.
He completed his undergraduate and MBA degrees from The Ohio State University.
Posizioni attive di Domenic Ciarico
Società | Posizione | Inizio |
---|---|---|
Par Sterile Products LLC
Par Sterile Products LLC Pharmaceuticals: GenericHealth Technology Par Sterile Products LLC engages in the development, manufacturing, and distribution of generic pharmaceuticals. Its products include adrenalin injection, adrenalin chloride solution, aplisol, argatroban injection, brevital sodium, buprenorphine HCL injection, CIII, colistimethate for injection, USP, coly-mycin m, dantrium IV, dantrium capsules, delestrogen, dexmedetomidine HCI, injection, ethacrynate sodium for injection, USP, fluphenazine decanoate injection, USP, ketalar, pitocin, tigan, triostat, vasostrict, and zoledronic acid injection. The company was founded in 2007 and is headquartered in Chestnut Ridge, NY. | Chief Executive Officer | 01/07/2018 |
Precedenti posizioni note di Domenic Ciarico
Società | Posizione | Fine |
---|---|---|
ENDO INTERNATIONAL PLC | Corporate Officer/Principal | - |
Formazione di Domenic Ciarico
The Ohio State University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Endo International Plc
Endo International Plc Pharmaceuticals: MajorHealth Technology Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. It operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment includes manufacturing, quality assurance, research and development, and administration functions. The Generic Pharmaceuticals segment is composed of manufacturing, distribution, quality assurance and administration functions, as well as certain research and development functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland. | Health Technology |
Par Sterile Products LLC
Par Sterile Products LLC Pharmaceuticals: GenericHealth Technology Par Sterile Products LLC engages in the development, manufacturing, and distribution of generic pharmaceuticals. Its products include adrenalin injection, adrenalin chloride solution, aplisol, argatroban injection, brevital sodium, buprenorphine HCL injection, CIII, colistimethate for injection, USP, coly-mycin m, dantrium IV, dantrium capsules, delestrogen, dexmedetomidine HCI, injection, ethacrynate sodium for injection, USP, fluphenazine decanoate injection, USP, ketalar, pitocin, tigan, triostat, vasostrict, and zoledronic acid injection. The company was founded in 2007 and is headquartered in Chestnut Ridge, NY. | Health Technology |
- Borsa valori
- Insiders
- Domenic Ciarico